These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 7638748)

  • 1. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
    Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a potent novel endotoxin antagonist.
    Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR; Lamping N; Hoess A
    J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
    Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
    J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
    J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
    Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL
    Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
    Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide binding and antibacterial activities of a synthetic peptide representing amino acids 90-101 of bactericidal/permeability-increasing protein.
    Yeh TM; Chao SC; Chang HC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Aug; 27(3):120-32. PubMed ID: 9747342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
    Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
    J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
    Dankesreiter S; Hoess A; Schneider-Mergener J; Wagner H; Miethke T
    J Immunol; 2000 May; 164(9):4804-11. PubMed ID: 10779788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and expression analysis on bactericidal permeability-increasing protein/lipopolysaccharide-binding protein of blunt snout bream, Megalobrama amblycephala.
    Tang L; Liang Y; Jiang Y; Liu S; Zhang F; He X; Wang T; Zhou Y; Zhong H; Yan J
    Fish Shellfish Immunol; 2015 Aug; 45(2):630-40. PubMed ID: 25982396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
    J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.